1. Home
  2. PACB

as of 12-31-2025 3:52pm EST

$1.87
+$0.14
+7.80%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Founded: 2000 Country:
United States
United States
Employees: N/A City: MENLO PARK
Market Cap: 715.5M IPO Year: 2010
Target Price: $2.08 AVG Volume (30 days): 6.3M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.71 EPS Growth: N/A
52 Week Low/High: $0.85 - $2.73 Next Earning Date: 02-12-2026
Revenue: $154,584,000 Revenue Growth: -10.72%
Revenue Growth (this year): 4.48% Revenue Growth (next year): 11.99%

AI-Powered PACB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 64.29%
64.29%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Pacific Biosciences of California Inc. News

PACB Breaking Stock News: Dive into PACB Ticker-Specific Updates for Smart Investing

All PACB News

Share on Social Networks: